This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw JSON (canonical form + also see JSON Format Specification)
Definition for Code System AdverseEventCausalityAssessment
{ "resourceType" : "CodeSystem", "id" : "adverse-event-causality-assess", "meta" : { "lastUpdated" : "2019-12-31T21:03:40.621+11:00" }, "text" : { "status" : "generated", "div" : "<div>!-- Snipped for Brevity --></div>" }, "extension" : [{ "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode" : "pc" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status", "valueCode" : "draft" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger" : 1 }], "url" : "http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess", "identifier" : [{ "system" : "urn:ietf:rfc:3986", "value" : "urn:oid:2.16.840.1.113883.4.642.1.1254" }], "version" : "4.2.0", "name" : "AdverseEventCausalityAssessment", "title" : "AdverseEventCausalityAssessment", "status" : "draft", "experimental" : false, "date" : "2019-12-31T21:03:40+11:00", "publisher" : "HL7 (FHIR Project)", "contact" : [{ "telecom" : [{ "system" : "url", "value" : "http://hl7.org/fhir" }, { "system" : "email", "value" : "fhir@lists.hl7.org" }] }], "description" : "Codes for the assessment of whether the entity caused the event.", "caseSensitive" : true, "valueSet" : "http://hl7.org/fhir/ValueSet/adverse-event-causality-assess", "content" : "complete", "concept" : [{ "code" : "certain", "display" : "Certain", "definition" : "i) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary." }, { "code" : "probably-likely", "display" : "Probably/Likely", "definition" : "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required." }, { "code" : "possible", "display" : "Possible", "definition" : "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear." }, { "code" : "unlikely", "display" : "Unlikely", "definition" : "i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations." }, { "code" : "conditional-classified", "display" : "Conditional/Classified", "definition" : "i) Event or laboratory test abnormality; ii) More data for proper assessment needed; or iii) Additional data under examination." }, { "code" : "unassessable-unclassifiable", "display" : "Unassessable/Unclassifiable", "definition" : "i) Report suggesting an adverse reaction; ii) Cannot be judged because information is insufficient or contradictory; or iii) Data cannot be supplemented or verified." }] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.